Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2015), Lancet, 386, 1353 - 1361

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2015), Lancet, 386, 1341 - 1352

Reply: To PMID 25495209.

Journal article

Rugkåsa J. et al, (2015), Acta Psychiatr Scand, 132

Hormone therapy and ovarian cancer - Authors' reply

Journal article

Beral V. et al, (2015), Lancet (London, England), 386, 1038 - 1039

Hormone therapy and ovarian cancer - Authors' reply.

Journal article

Beral V. et al, (2015), Lancet, 386, 1038 - 1039

Tuesday, 1 September 2015

Journal article

(2015), European Heart Journal, 36, 849 - 1187